Neither is universally "better." The right choice depends on the injury type, location, chronicity, your budget, and whether you value convenience or concentrated local delivery
The SURMOUNT trials in patients without diabetes showed even greater weight loss, with the 15 mg dose producing an average loss of 20.9 percent of body weight at 72 weeks compared to 14.9 percent for semaglutide in similar populations
For dietary deficiency where absorption is intact, oral cyanocobalamin is typically recommended in the UK
Using research-grade peptides without medical oversight carries significant health risks
[DOI] [PubMed] [Google Scholar] 132.Chen SC, Eiting K, Cui K, et al
Studies from multiple independent groups across musculoskeletal injury, gastrointestinal disease, vascular injury, and neurological insult have reported positive outcomes